- Home
- PEGA vs ASND Comparison
PEGA vs ASND Comparison
Compare PEGA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEGA
- ASND
- Stock Information
- Founded
- PEGA 1983
- ASND 2006
- Country
- PEGA United States
- ASND Denmark
- Employees
- PEGA N/A
- ASND N/A
- Industry
- PEGA EDP Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- PEGA Technology
- ASND Health Care
- Exchange
- PEGA Nasdaq
- ASND Nasdaq
- Market Cap
- PEGA 9.4B
- ASND 9.9B
- IPO Year
- PEGA 1996
- ASND 2015
- Fundamental
- Price
- PEGA $57.40
- ASND $174.48
- Analyst Decision
- PEGA Buy
- ASND Strong Buy
- Analyst Count
- PEGA 14
- ASND 17
- Target Price
- PEGA $56.04
- ASND $222.71
- AVG Volume (30 Days)
- PEGA 2.0M
- ASND 445.3K
- Earning Date
- PEGA 07-22-2025
- ASND 09-02-2025
- Dividend Yield
- PEGA 0.10%
- ASND N/A
- EPS Growth
- PEGA 61.54
- ASND N/A
- EPS
- PEGA 1.18
- ASND N/A
- Revenue
- PEGA $1,676,025,000.00
- ASND $398,509,511.00
- Revenue This Year
- PEGA $15.75
- ASND $79.35
- Revenue Next Year
- PEGA $6.23
- ASND $76.18
- P/E Ratio
- PEGA $48.80
- ASND N/A
- Revenue Growth
- PEGA 12.47
- ASND 12.06
- 52 Week Low
- PEGA $29.84
- ASND $111.09
- 52 Week High
- PEGA $60.96
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- PEGA 59.89
- ASND 55.63
- Support Level
- PEGA $57.08
- ASND $160.86
- Resistance Level
- PEGA $60.96
- ASND $175.88
- Average True Range (ATR)
- PEGA 2.16
- ASND 6.43
- MACD
- PEGA 0.44
- ASND 0.07
- Stochastic Oscillator
- PEGA 69.28
- ASND 71.32
About PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.